Posts Tagged: Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA


IP Due Diligence in the Life Sciences: Key Considerations for 2019

The success of a life science product, and thereby the company, rests heavily upon a combination of patent protection, regulatory exclusivity and product life cycle management. A …